ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics
November 17, 2018NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today announces the appointment of Dr. Anthony Tolcher to NBE's Scientific Advisory Board (SAB). -
Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics
November 17, 2018NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today announces the appointment of Dr. Anthony Tolcher to NBE's Scientific Advisory Board (SAB).
Pharma Sources Insight January 2025
